Navigation Links
First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions
Date:11/13/2007

is going to take all of us, working together united in this fight to discover and deliver the cures for this dreaded disease. We have to commit to mobilizing people, ensuring open dialogue and maximizing funding if we are to end breast cancer. Cancer as a whole kills some 7 million people around the globe each year," said Hala Moddelmog, President and CEO of Susan G. Komen for the Cure. "Since our inception 25 years ago, Susan G. Komen for the Cure has invested in breast cancer research and community outreach programs, and over the next decade, we plan to increase our investment to demonstrate the seriousness of our commitment."

The Collaborative Summit opened with an address by the Honorable John Edwards Porter, Vice Chairman of the Board of the Foundation for the National Institutes of Health, followed by Ambassador Nancy G. Brinker, founder of Susan G. Komen for the Cure, the world's largest grassroots network of survivors and activist committed to ending breast cancer forever. Ambassador Brinker, spoke on the nation's "funding landscape" as a leader in the non- governmental and non-profit sector, saying, "I believe in this partnership between science and society. It is the collaboration between so many of us, (that) lies at the heart of our progress in this fight ... let's use this summit to start building a new culture, a culture of collaboration."

The participants made an appraisal of the current breast cancer landscape; held frank, open discussions on current barriers to prevention and cure; and developed compelling action steps for making significant, expedited progress forward. In addition to the specific goals, the open dialogue among disparate members of the breast cancer community itself broke barriers, creating a new paradigm for constructive movement forward towards innovative initiatives, new models, partnership opportunities and potential collaborations.

"Working together with our partners who raise funds for breast cancer research
'/>"/>

SOURCE Avon Foundation; Susan G. Komen for the Cure
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
2. Fred Hutchinson Cancer Research Center Announces the First-Ever Expedition to an Unclimbed Mountain in the Name of Cancer Research
3. Y-ME Illinois Hosts the First-Ever BIG Night Out - Indulgence for a Cause
4. TriWest and Alaska VA Hosted First-Ever PTSD State-Wide Seminars to Reach Rural Health Care Providers
5. Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest
6. AACR to host first-ever meeting on the science of cancer health disparities
7. E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries
8. Health care incentive model offers collaborative approach
9. Sanofi-aventis US Chairman Tim Rothwell Addresses CMSAs Collaborative Practice Summit
10. Collaborative Drug Discovery, Inc. and St. Jude Childrens Research Hospital Make Malaria Research Data Available to Speed Drug Development
11. Free Access to Literature Data on Chagas Disease Offered Online: Collaborative Drug Discovery, Inc. provides Neglected Disease researchers with archive mine and collaborate access to small molecule bioactivity SAR data on parasitic disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 2015 As a provider of holistic, ... that their rehabilitation strategy, which involves various treatment modalities, ... In an effort to offer hope and encouragement to ... lives, Best Drug Rehabilitation has featured a series of ... successful graduates of their recovery program. , One ...
(Date:4/21/2015)... Zane Benefits, the leader in individual ... publication of a new guide “Health Reimbursement Accounts in ... the health insurance industry, including how employers can use ... what is permitted when implementing an HRA. This simple, ... which HRAs are compliant this year. , According ...
(Date:4/21/2015)... April 21, 2015 Zane Benefits, a ... today its CEO Rick Lindquist has been selected as ... , According to Rick Lindquist, “There is a massive ... Zane Benefits’ small business solutions are at its forefront. ... by Employee Benefit Adviser’s Rising Stars.” , According to ...
(Date:4/21/2015)... 21, 2015 Optimity Advisors ( ... advisory firm that helps clients in complex industries ... that the Association of Community Affiliated Plans ... ACAP represents 58 local, not-for-profit, community-affiliated Safety Net ... million people primarily enrolled in public or state-sponsored ...
(Date:4/21/2015)... When a bandage sticks to an injury site ... solve this problem two inventors from Festus, Mo., designed ... helps a cut, burn, abrasion or wound heal more ... The bandage is easy to use, versatile and producible ... to the St. Louis office of InventHelp. It is ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Graduate Discusses Making Amends and Rebuilding Relationships 2Health News:Zane Benefits’ CEO Named Top 20 Rising Stars 2Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2
... develop certain hereditary cancers develop them at earlier ages than ... CANCER , a peer-reviewed journal of the American Cancer Society, ... of cancer diagnosis to determine when to provide counseling, screening, ... the BRCA genes have a high risk of developing breast ...
... , SATURDAY, Sept. 10 (HealthDay News) -- It,s important for ... their children to do their homework, a new study suggests. ... toward homework improves if parents take a positive, supportive attitude ... the assignment or getting a higher grade. The study ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, ... Administration advisers recommended Friday that osteoporosis drugs such as ... clarifying how long a patient should take a drug ... drugs, known as bisphosphonates, are taken to prevent fractures ...
... Preliminary research on Fusarium , a group of ... shows how these microbes travel through the air. ... research, there will be a better understanding about crop ... are steering their efforts towards a new aerobiological modeling ...
... A new study finds that lung cancer patients ... percentage of uninsured and Medicaid-insured patients, so-called "high ... undergo surgery that was intended to cure the ... burden facilities. This difference persisted even after controlling ...
... , FRIDAY, Sept. 9 (HealthDay News) -- One-third ... inherited metabolic disorder, a new study finds. This ... produced naturally from many foods -- that has a foul, ... a disease that impairs the ability of an enzyme to ...
Cached Medicine News:Health News:Women who inherit BRCA gene mutations develop cancer earlier than their ancestors 2Health News:Parents' Positive Attitude Can Help Kids Get Homework Done 2Health News:FDA Advisers Call for Revised Labels for Osteoporosis Drugs 2Health News:FDA Advisers Call for Revised Labels for Osteoporosis Drugs 3Health News:Microbes travel through the air; it would be good to know how and where 2Health News:Microbes travel through the air; it would be good to know how and where 3Health News:Study finds hospitals of last resort deliver lower quality of lung cancer care 2
(Date:4/21/2015)... ST. LOUIS , April 21, 2015 ... as a 5.4 percent decrease in utilization helped offset ... according to new data released today by Express Scripts ... Express Scripts Workers, Compensation Drug Trend Report discusses the ... opioid use among injured workers. Opioid ...
(Date:4/21/2015)... , April 21, 2015  The American ... U.S. Food and Drug Administration that the agency,s ... for the last 25 years to protect the ... homeopathic medicines. AAHP, the industry,s trade association, was ... of homeopathic medicines to engage in productive discussions ...
(Date:4/21/2015)... NEW YORK , April 21, 2015 ... of amendments to its Clinical Trial Authorizations (CTAs) filed ... Regulatory Agency (MHRA) and Germany,s ... (BfArM) for the expansion of the Company,s global Phase ... hepatocellular carcinoma (primary liver cancer, or HCC), to include ...
Breaking Medicine Technology:Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 2Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 3Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 4Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework 2Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 2Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 3Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 4
... - First prospective biomarker trial in non-small cell ... /PRNewswire-FirstCall/ -- Response,Genetics, Inc. today announced that positive ... issue of the Journal of Clinical,Oncology suggests that ... in patient biopsies,with advanced non-small cell lung cancer ...
... LOS ANGELES--(BUSINESS WIRE)--July 8, 2007 - Cougar Biotechnology,Inc. ... Phase,II data on the Company's prostate cancer drug ... Society for,Medical Oncology (ESMO) Conference, which is currently ... in two oral and,poster presentations on Sunday, July ...
Cached Medicine Technology:Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 2Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 3Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 4Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 4Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 5Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 6
... Nidek GYC-1000 delivers a solid-state ... of energy and plugs into ... compact design and extreme portability, ... with the Nidek Phaco Emulsification ...
There are many reasons to choose the CardioGenesis 2000 Holmium:YAG Laser System for TMR in your hospital or medical facility. Among the first is the CardioGenesis commitment to deliver the highest q...
Total T3 EIA Thyroid Function 025-BC-1005...
... The anti-TG test kit is a solid ... format. It is designed for the quantitative ... (TG) in serum or plasma. The microplate ... Calibrators, controls and patient samples are pipetted ...
Medicine Products: